Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	T cell receptor complex	TRAV9-2 TRA TRGV3 TRBV10-3 TRBV10-2 TRBV10-1 TRAV38-2DV8 TRAV38-1 TRAV13-1	7.01e-06	163	168	9	GO:0042101
GeneOntologyCellularComponent	receptor complex	TRAV9-2 VLDLR DRD1 TRA TRGV3 ITPR2 LIFR IGHD TRBV10-3 TRBV10-2 TRBV10-1 TRAV38-2DV8 TRAV38-1 KIT PLXNB1 TRAV13-1	1.93e-05	581	168	16	GO:0043235
GeneOntologyCellularComponent	axon	MAPK8IP1 NRG1 DRD1 NRCAM SARM1 NTSR1 ADGRL1 CBL DSCAML1 CADM2 TIAM2 ITPR2 AVIL DOCK7 SLC4A10 PALLD DCLK1 UNC80 CNTN1	1.04e-04	891	168	19	GO:0030424
GeneOntologyCellularComponent	plasma membrane signaling receptor complex	TRAV9-2 DRD1 TRA TRGV3 IGHD TRBV10-3 TRBV10-2 TRBV10-1 TRAV38-2DV8 TRAV38-1 TRAV13-1	1.29e-04	350	168	11	GO:0098802
Domain	-	MAPK8IP1 AGAP5 ARHGEF28 TNS2 TIAM2 ARHGEF10L PLEK2 PLEKHG3 DGKK MTMR3 APPL1 TLN2 GAB1 ARAP2 PHLPP2	9.45e-07	391	155	15	2.30.29.30
Domain	PH_dom-like	MAPK8IP1 AGAP5 ARHGEF28 TNS2 TIAM2 ARHGEF10L PLEK2 PLEKHG3 DGKK MTMR3 APPL1 TLN2 GAB1 ARAP2 PHLPP2	2.73e-06	426	155	15	IPR011993
Domain	Ig-like_fold	NRG1 FLNB NRCAM TRA DSCAML1 CADM2 LIFR HMCN1 PTPRH IGHD TRIM9 CD101 MID1 HCFC2 LY9 KIT PALLD PLXNB1 CNTN1	6.41e-06	706	155	19	IPR013783
Domain	fn3	NRCAM DSCAML1 LIFR PTPRH TRIM9 MID1 HCFC2 CNTN1	6.30e-05	162	155	8	PF00041
Domain	PH_DOMAIN	AGAP5 ARHGEF28 TIAM2 PLEK2 PLEKHG3 DGKK APPL1 GAB1 ARAP2 PHLPP2	1.15e-04	279	155	10	PS50003
Domain	-	NRG1 FLNB NRCAM DSCAML1 CADM2 LIFR HMCN1 TRIM9 CD101 MID1 HCFC2 LY9 KIT PALLD PLXNB1 CNTN1	1.30e-04	663	155	16	2.60.40.10
Domain	FN3	NRCAM DSCAML1 LIFR PTPRH TRIM9 MID1 HCFC2 CNTN1	1.59e-04	185	155	8	SM00060
Domain	Ig_I-set	NRG1 NRCAM DSCAML1 CADM2 HMCN1 CD101 PALLD CNTN1	1.91e-04	190	155	8	IPR013098
Domain	I-set	NRG1 NRCAM DSCAML1 CADM2 HMCN1 CD101 PALLD CNTN1	1.91e-04	190	155	8	PF07679
Domain	SPAR_C	SIPA1L1 SIPA1L2	2.04e-04	3	155	2	PF11881
Domain	SIPA1L_C	SIPA1L1 SIPA1L2	2.04e-04	3	155	2	IPR021818
Domain	FN3	NRCAM DSCAML1 LIFR PTPRH TRIM9 MID1 HCFC2 CNTN1	2.61e-04	199	155	8	PS50853
Domain	IRK	KCNJ1 KCNJ10 KCNJ15	2.90e-04	16	155	3	PF01007
Domain	K_chnl_inward-rec_Kir_cyto	KCNJ1 KCNJ10 KCNJ15	2.90e-04	16	155	3	IPR013518
Domain	-	KCNJ1 KCNJ10 KCNJ15	2.90e-04	16	155	3	2.60.40.1400
Domain	K_chnl_inward-rec_Kir	KCNJ1 KCNJ10 KCNJ15	2.90e-04	16	155	3	IPR016449
Domain	FN3_dom	NRCAM DSCAML1 LIFR PTPRH TRIM9 MID1 HCFC2 CNTN1	3.63e-04	209	155	8	IPR003961
Domain	Tap_RNA_bd	NXF5 NXF1	4.06e-04	4	155	2	PD043466
Domain	Tap_RNA-bd	NXF5 NXF1	4.06e-04	4	155	2	IPR015245
Domain	Tap-RNA_bind	NXF5 NXF1	4.06e-04	4	155	2	PF09162
Domain	PH	AGAP5 ARHGEF28 TIAM2 PLEK2 PLEKHG3 DGKK APPL1 GAB1 ARAP2	5.34e-04	278	155	9	SM00233
Domain	PH_domain	AGAP5 ARHGEF28 TIAM2 PLEK2 PLEKHG3 DGKK APPL1 GAB1 ARAP2	5.62e-04	280	155	9	IPR001849
Domain	IGc2	NRG1 NRCAM DSCAML1 CADM2 HMCN1 KIT PALLD CNTN1	7.86e-04	235	155	8	SM00408
Domain	Ig_sub2	NRG1 NRCAM DSCAML1 CADM2 HMCN1 KIT PALLD CNTN1	7.86e-04	235	155	8	IPR003598
Domain	SUN	SUN1 SUN2	1.00e-03	6	155	2	PS51469
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARHGEF28 DRG2 KIF26B CBL FAM83B ARFGEF3 STOX2 LIMK2 TRIM9 PLEKHG3 SIPA1L1 DOCK7 NAV2 SIPA1L2 PALLD DCLK1 GAB1 ARAP2	2.86e-07	861	171	18	36931259
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CASP8AP2 DSCAML1 TRIM9 SIPA1L1 NAV2 APPL1 TLN2 UNC80 PCNT	1.90e-06	225	171	9	12168954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NRCAM ADGRL1 SMARCAD1 ARFGEF3 SIPA1L1 PCDH19 MTMR3 DOCK7 SIPA1L2 ARAP2 PCNT	6.10e-06	407	171	11	12693553
Pubmed	Identification of candidate maternal-effect genes through comparison of multiple microarray data sets.	GCM2 MSH3 SSPN NAV2 KIT	6.42e-06	53	171	5	16964442
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	FLNB CTC1 SUN1 SLC35A1 ETS1 APOB THOC2 ZNF568 TIAM2 RPS6KC1 SSPN KCNJ1 SIPA1L1 NFX1 PCDH18 DCLK1 PLXNB1 PCNT	7.30e-06	1084	171	18	11544199
Pubmed	NXF5, a novel member of the nuclear RNA export factor family, is lost in a male patient with a syndromic form of mental retardation.	NXF5 NFX1 NXF1	9.60e-06	9	171	3	11566096
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	AGAP5 NRCAM SIPA1L1 KCNJ10 PKP1 APPL1 TLN2 RIMS2 DCLK1	1.15e-05	281	171	9	28706196
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MAPK8IP1 FLNB NRCAM VEZT SUN1 ADGRL1 SRPRB RPS6KC1 ARFGEF3 TRIM9 SIPA1L1 DOCK7 SLC4A10 PKP1 APPL1 TLN2 SIPA1L2 DCLK1	1.42e-05	1139	171	18	36417873
Pubmed	Sun1 deficiency leads to cerebellar ataxia in mice.	SUN1 SUN2	2.40e-05	2	171	2	26035387
Pubmed	SUN1/2 controls macrophage polarization via modulating nuclear size and stiffness.	SUN1 SUN2	2.40e-05	2	171	2	37828059
Pubmed	Inner nuclear envelope proteins SUN1 and SUN2 play a prominent role in the DNA damage response.	SUN1 SUN2	2.40e-05	2	171	2	22863315
Pubmed	Cloning and characterization of two K+ inward rectifier (Kir) 1.1 potassium channel homologs from human kidney (Kir1.2 and Kir1.3).	KCNJ10 KCNJ15	2.40e-05	2	171	2	8995301
Pubmed	Differential incorporation of SUN-domain proteins into LINC complexes is coupled to gene expression.	SUN1 SUN2	2.40e-05	2	171	2	29813079
Pubmed	Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons.	MAPK8IP1 ARHGEF28	2.40e-05	2	171	2	10574993
Pubmed	Phage display of a human antibody against Clostridium tetani toxin.	IGKV1-39 IGKV1D-39	2.40e-05	2	171	2	7926831
Pubmed	Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.	CBL KIT	2.40e-05	2	171	2	16780420
Pubmed	Hunting for Familial Parkinson's Disease Mutations in the Post Genome Era.	SIPA1L1 KCNJ15	2.40e-05	2	171	2	33802862
Pubmed	SUN proteins facilitate the removal of membranes from chromatin during nuclear envelope breakdown.	SUN1 SUN2	2.40e-05	2	171	2	24662567
Pubmed	Muscular dystrophy-associated SUN1 and SUN2 variants disrupt nuclear-cytoskeletal connections and myonuclear organization.	SUN1 SUN2	2.40e-05	2	171	2	25210889
Pubmed	SUN1/2 Are Essential for RhoA/ROCK-Regulated Actomyosin Activity in Isolated Vascular Smooth Muscle Cells.	SUN1 SUN2	2.40e-05	2	171	2	31935926
Pubmed	UNC-84 localizes to the nuclear envelope and is required for nuclear migration and anchoring during C. elegans development.	SUN1 SUN2	2.40e-05	2	171	2	10375507
Pubmed	Role of a Contactin multi-molecular complex secreted by oligodendrocytes in nodal protein clustering in the CNS.	NRCAM CNTN1	2.40e-05	2	171	2	31328333
Pubmed	Effects of Inner Nuclear Membrane Proteins SUN1/UNC-84A and SUN2/UNC-84B on the Early Steps of HIV-1 Infection.	SUN1 SUN2	2.40e-05	2	171	2	28747499
Pubmed	CD72 negatively regulates KIT-mediated responses in human mast cells.	CD72 KIT	2.40e-05	2	171	2	20100931
Pubmed	Nuclear-cytoskeletal linkages facilitate cross talk between the nucleus and intercellular adhesions.	SUN1 SUN2	2.40e-05	2	171	2	25963820
Pubmed	Characterization of the structures involved in localization of the SUN proteins to the nuclear envelope and the centrosome.	SUN1 SUN2	2.40e-05	2	171	2	17132086
Pubmed	Specific localization of an inwardly rectifying K(+) channel, Kir4.1, at the apical membrane of rat gastric parietal cells; its possible involvement in K(+) recycling for the H(+)-K(+)-pump.	KCNJ10 KCNJ15	2.40e-05	2	171	2	11927671
Pubmed	Analysis of meiosis in SUN1 deficient mice reveals a distinct role of SUN2 in mammalian meiotic LINC complex formation and function.	SUN1 SUN2	2.40e-05	2	171	2	24586178
Pubmed	Structural conservation of the autoinhibitory domain in SUN proteins.	SUN1 SUN2	2.40e-05	2	171	2	29408528
Pubmed	Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer.	ZFHX3 MUC5AC	2.40e-05	2	171	2	17330845
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	MTMR3 RIMS2 MUC5AC UNC80 SPINK5	2.71e-05	71	171	5	33541421
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	VLDLR ERCC6 HECTD3 VEZT KIAA1549 SMARCAD1 LIMK2 SH3TC1 PRPF4 SUN2 SIPA1L1 PCDH19 ZFHX3 SIPA1L2 UNC80 ANAPC4 ARAP2	3.94e-05	1116	171	17	31753913
Pubmed	International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels.	KCNJ1 KCNJ10 KCNJ15	5.09e-05	15	171	3	16382105
Pubmed	Structure and implied functions of truncated B-cell receptor mRNAs in early embryo and adult mesenchymal stem cells: Cdelta replaces Cmu in mu heavy chain-deficient mice.	IGKV1-39 IGHD IGKV1D-39	6.24e-05	16	171	3	17124007
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CASP8AP2 AGAP5 SUN1 KIAA1549 TIAM2 ARHGEF10L STOX2 TRIM9 NAV2 RIMS2 PLXNB1	6.74e-05	529	171	11	14621295
Pubmed	Immunoglobulin genes of the kappa light chain type from two human lymphoid cell lines are closely related.	IGKV1-39 IGKV1D-39	7.19e-05	3	171	2	6091049
Pubmed	Activation of Dopamine D1 Receptors in Dermal Fibroblasts Restores Vascular Endothelial Growth Factor-A Production by These Cells and Subsequent Angiogenesis in Diabetic Cutaneous Wound Tissues.	DRD1 DOCK7	7.19e-05	3	171	2	27422612
Pubmed	Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice.	AHSG KIT	7.19e-05	3	171	2	8695840
Pubmed	TAP/NXF1, the primary mRNA export receptor, specifically interacts with a neuronal RNA-binding protein HuD.	NFX1 NXF1	7.19e-05	3	171	2	15358174
Pubmed	CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα.	CD72 KIT	7.19e-05	3	171	2	25239131
Pubmed	Akt2- and ETS1-dependent IP3 receptor 2 expression in dendritic cell migration.	ETS1 ITPR2	7.19e-05	3	171	2	24496246
Pubmed	Whole exome sequencing identifies KIF26B, LIFR and LAMC1 mutations in familial vesicoureteral reflux.	KIF26B LIFR	7.19e-05	3	171	2	36417404
Pubmed	The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia.	CBL KIT	7.19e-05	3	171	2	23783394
Pubmed	RapGAPs in brain: multipurpose players in neuronal Rap signalling.	SIPA1L1 SIPA1L2	7.19e-05	3	171	2	20576033
Pubmed	Jaw1/LRMP has a role in maintaining nuclear shape via interaction with SUN proteins.	SUN1 SUN2	7.19e-05	3	171	2	29878215
Pubmed	Kcnj16 (Kir5.1) Gene Ablation Causes Subfertility and Increases the Prevalence of Morphologically Abnormal Spermatozoa.	KCNJ10 KCNJ15	7.19e-05	3	171	2	34205849
Pubmed	Dynamics and molecular interactions of linker of nucleoskeleton and cytoskeleton (LINC) complex proteins.	SUN1 SUN2	7.19e-05	3	171	2	19843581
Pubmed	The LINC complex is essential for hearing.	SUN1 SUN2	7.19e-05	3	171	2	23348741
Pubmed	E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease.	CBL KIT	7.19e-05	3	171	2	19734451
Pubmed	Identification and characterization of three members of a novel subclass of protocadherins.	PCDH19 PCDH18	7.19e-05	3	171	2	11549318
Pubmed	CSF-1-induced Src signaling can instruct monocytic lineage choice.	CSF1 KIT	7.19e-05	3	171	2	28159742
Pubmed	F3/contactin and TAG1 play antagonistic roles in the regulation of sonic hedgehog-induced cerebellar granule neuron progenitor proliferation.	NRCAM CNTN1	7.19e-05	3	171	2	21205796
Pubmed	Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis.	CD72 PLXNB1	7.19e-05	3	171	2	20038643
Pubmed	Interaction of the Ca2+-sensing receptor with the inwardly rectifying potassium channels Kir4.1 and Kir4.2 results in inhibition of channel function.	KCNJ10 KCNJ15	7.19e-05	3	171	2	17122384
Pubmed	PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.	CBL PLEK2	7.19e-05	3	171	2	31182136
Pubmed	Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils.	LIFR KIT	7.19e-05	3	171	2	26066745
Pubmed	CircCDC45 promotes the malignant progression of glioblastoma by modulating the miR-485-5p/CSF-1 axis.	CDC45 CSF1	7.19e-05	3	171	2	34627193
Pubmed	Macrophages fine-tune pupil shape during development.	DLL4 CSF1	7.19e-05	3	171	2	32565279
Pubmed	Induction of dendritic cell-like phenotype in macrophages during foam cell formation.	APOB CSF1	7.19e-05	3	171	2	17244792
Pubmed	Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl.	CBL KIT	7.19e-05	3	171	2	17904548
Pubmed	Induction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase beta.	NRCAM CNTN1	7.19e-05	3	171	2	9049255
Pubmed	Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium.	NRG1 MUC5AC	7.19e-05	3	171	2	19556605
Pubmed	Functional natural killer T cells in experimental mouse strains, including NK1.1- strains.	KIT KLRB1	7.19e-05	3	171	2	11109539
Pubmed	Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl).	CBL KIT	7.19e-05	3	171	2	15315962
Pubmed	Nuclear envelope-associated endosomes deliver surface proteins to the nucleus.	SUN1 SUN2	7.19e-05	3	171	2	26356418
Pubmed	A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome.	OR2T29 KIF26B COP1 OR2T5 APOB NAV2 UNC80	7.39e-05	205	171	7	12040188
Pubmed	A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales.	CADM2 TG PCDH18	7.55e-05	17	171	3	22832960
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	KIF26B ARFGEF3 SIPA1L1 DOCK7 SIPA1L2 PALLD GAB1	8.34e-05	209	171	7	36779422
Pubmed	Architectural niche organization by LHX2 is linked to hair follicle stem cell function.	FLNB PALLD PCNT	9.03e-05	18	171	3	24012369
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	AGAP5 STOX2 TRIM9 SIPA1L1 HCFC2 SIPA1L2 MYO16	1.08e-04	218	171	7	33378226
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	CASP8AP2 STOX2 PCDH19 NAV2 APPL1 SIPA1L2	1.15e-04	153	171	6	10718198
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	NRG1 KIAA1549 APOB FAM83B PLEK2 DOCK7 NAV2 PCDH18 PLXNB1 GAB1 ARAP2	1.28e-04	569	171	11	30639242
Pubmed	Grb2-associated binder-1 is required for neuregulin-1-induced peripheral nerve myelination.	NRG1 GAB1	1.43e-04	4	171	2	24872569
Pubmed	Expression of CSF-1/c-fms and SF/c-kit mRNA during preimplantation mouse development.	CSF1 KIT	1.43e-04	4	171	2	1374350
Pubmed	Lack of KIT or FMS internal tandem duplications but co-expression with ligands in AML.	CSF1 KIT	1.43e-04	4	171	2	14654075
Pubmed	Role of Angiotensin II Type 1a Receptor (AT1aR) of Renal Tubules in Regulating Inwardly Rectifying Potassium Channels 4.2 (Kir4.2), Kir4.1, and Epithelial Na+ Channel (ENaC).	KCNJ10 KCNJ15	1.43e-04	4	171	2	37909221
Pubmed	Generation and characterization of an Nxf7 knockout mouse to study NXF5 deficiency in a patient with intellectual disability.	NXF5 NXF1	1.43e-04	4	171	2	23675524
Pubmed	Analysis of interactions of the adhesion molecule TAG-1 and its domains with other immunoglobulin superfamily members.	NRCAM CNTN1	1.43e-04	4	171	2	12139915
Pubmed	Bortezomib enhances the therapeutic efficacy of dasatinib by promoting c-KIT internalization-induced apoptosis in gastrointestinal stromal tumor cells.	CBL KIT	1.43e-04	4	171	2	25737303
Pubmed	Coupling of the nucleus and cytoplasm: role of the LINC complex.	SUN1 SUN2	1.43e-04	4	171	2	16380439
Pubmed	Cooperative interaction of hepatocyte growth factor and neuregulin regulates Schwann cell migration and proliferation through Grb2-associated binder-2 in peripheral nerve repair.	NRG1 GAB1	1.43e-04	4	171	2	28722233
Pubmed	Dopamine-Evoked Synaptic Regulation in the Nucleus Accumbens Requires Astrocyte Activity.	DRD1 ITPR2	1.43e-04	4	171	2	31954621
Pubmed	Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development.	SUN1 SUN2	1.43e-04	4	171	2	20108321
Pubmed	Nesprin-1α-Dependent Microtubule Nucleation from the Nuclear Envelope via Akap450 Is Necessary for Nuclear Positioning in Muscle Cells.	SUN1 SUN2	1.43e-04	4	171	2	28966089
Pubmed	cAMP-responding element-binding protein and c-Ets1 interact in the regulation of ATP-dependent MUC5AC gene expression.	ETS1 MUC5AC	1.43e-04	4	171	2	18676374
Pubmed	Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1.	CBL GAB1	1.43e-04	4	171	2	9242692
Pubmed	The SUN2-nesprin-2 LINC complex and KIF20A function in the Golgi dispersal.	SUN1 SUN2	1.43e-04	4	171	2	33686165
Pubmed	Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis.	NTSR1 KIT	1.43e-04	4	171	2	18376408
Pubmed	Context-Specific Striatal Astrocyte Molecular Responses Are Phenotypically Exploitable.	ITPR2 KCNJ10	1.43e-04	4	171	2	33086039
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ZNF280D KIAA1549 ARHGEF10L TRPM3 PCDH18	1.47e-04	101	171	5	10997877
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	NRCAM DSCAML1 CADM2 HMCN1 LY9 CNTN1	1.57e-04	162	171	6	25826454
Pubmed	Rare independent mutations in renal salt handling genes contribute to blood pressure variation.	KCNJ1 KCNJ10 KCNJ15	1.68e-04	22	171	3	18391953
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ARHGEF28 SARM1 SAMD9L TRPM3 PLEKHG3 SUN2 APPL1 PCDH18 PALLD UNC80	1.77e-04	493	171	10	15368895
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	DRD1 TRA SLC35A1 ETS1 ARHGEF10L CSF1 SIPA1L1 NAV2 HSP90AB2P PCDH18 DCLK1 MYO16 ARAP2	2.09e-04	814	171	13	23251661
Pubmed	Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.	CSF1 CCL23	2.38e-04	5	171	2	18668547
Pubmed	Fragile X mental retardation protein FMRP and the RNA export factor NXF2 associate with and destabilize Nxf1 mRNA in neuronal cells.	NXF5 NXF1	2.38e-04	5	171	2	17548835
Pubmed	Mammalian SUN protein interaction networks at the inner nuclear membrane and their role in laminopathy disease processes.	SUN1 SUN2	2.38e-04	5	171	2	19933576
Pubmed	Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling.	NRG1 GAB1	2.38e-04	5	171	2	17571162
Pubmed	A mast cell-thermoregulatory neuron circuit axis regulates hypothermia in anaphylaxis.	AVIL KIT	2.38e-04	5	171	2	36930731
Pubmed	A molecular mechanism for LINC complex branching by structurally diverse SUN-KASH 6:6 assemblies.	SUN1 SUN2	2.38e-04	5	171	2	33393904
Interaction	TRIM52 interactions	BRIP1 CTC1 ZNF195 POLR3A MYO5C POLR1B SIPA1L2 INVS PCNT	1.18e-06	133	160	9	int:TRIM52
Cytoband	9p13.3	SPAG8 FAM221B NFX1 CD72	1.84e-04	75	171	4	9p13.3
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NRG1 NRCAM DSCAML1 CADM2 HMCN1 CD101 PALLD CNTN1	9.96e-06	161	117	8	593
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	AGAP5 TIAM2 PLEK2 PLEKHG3 APPL1 GAB1 ARAP2 PHLPP2	5.84e-05	206	117	8	682
GeneFamily	Fibronectin type III domain containing	NRCAM DSCAML1 LIFR PTPRH TRIM9 MID1 CNTN1	8.18e-05	160	117	7	555
GeneFamily	Potassium voltage-gated channel subfamily J	KCNJ1 KCNJ10 KCNJ15	1.39e-04	16	117	3	276
GeneFamily	T-cell receptor alpha locus at 14q11.2	TRAV9-2 TRA TRAV38-2DV8 TRAV38-1 TRAV13-1	9.80e-04	117	117	5	371
GeneFamily	Immunoglobulin like domain containing	NRCAM DSCAML1 CD101 LY9 KIT CNTN1	1.61e-03	193	117	6	594
GeneFamily	Non-clustered protocadherins	PCDH19 PCDH18	2.63e-03	12	117	2	21
GeneFamily	PDZ domain containing	TIAM2 LIMK2 SIPA1L1 SIPA1L2 RIMS2	3.10e-03	152	117	5	1220
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM KIF26B APOB DSCAML1 CADM2 ARFGEF3 HMCN1 TRPM3 DGKK TLN2 MYO16 UNC80 CNTN1	3.31e-13	184	170	13	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM KIF26B APOB DSCAML1 CADM2 ARFGEF3 HMCN1 TRPM3 DGKK TLN2 MYO16 UNC80 CNTN1	3.31e-13	184	170	13	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM KIF26B APOB DSCAML1 CADM2 ARFGEF3 HMCN1 TRPM3 DGKK TLN2 MYO16 UNC80 CNTN1	3.31e-13	184	170	13	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Int-URO-Lymphocyte-T_NK-MAIT\|Int-URO / Disease, Lineage and Cell Type	AGAP5 TTC16 MYO5C TMEM171 TRBV10-3 SLC4A10 GPR171 TMPRSS7 KLRB1	2.43e-08	174	170	9	5227ed29f5f0d3e0aaa7f3cfd362f96d3e2660f7
ToppCell	Severe-Lymphoid-T-innate_T\|Severe / Condition, Lineage, Cell class and cell subclass	NBPF3 TRGV3 ETS1 TMEM171 TRBV10-2 SLC4A10 GPR171 TRAV38-2DV8 KLRB1	3.42e-08	181	170	9	50ab8562552339d97e4f19aa6ae49fd797da492e
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRG1 ARHGEF28 NRCAM KIAA1549 DSCAML1 STOX2 TRPM3 KCNJ15 RIMS2	3.76e-08	183	170	9	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLNB ARHGEF28 ATP8B1 MYO5C ARFGEF3 RANBP17 STOX2 LIMK2 MID1	8.05e-08	200	170	9	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Healthy_Control-Lymphoid-T-innate_T\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	TRGV3 ETS1 SLC4A10 GPR171 TRAV38-2DV8 KIT KLRB1 TRAV13-1	2.44e-07	165	170	8	1ade67229b50fe20eb392262a3e1ee4306b73290
ToppCell	Bronchial_Biopsy-Epithelial-Ionocytes\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	NRCAM DLL4 WDR88 APOB ITPR2 C12orf42 KIT UNC80	3.82e-07	175	170	8	13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NRG1 MYO5C RANBP17 STOX2 NAV2 MYO16 GAB1 ARAP2	5.59e-07	184	170	8	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NRG1 MYO5C RANBP17 STOX2 NAV2 MYO16 GAB1 ARAP2	5.59e-07	184	170	8	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Tuft\|World / Class top	FLNB NRCAM ITPR2 AVIL NAV2 AHSG KIT DCLK1	6.07e-07	186	170	8	f4d83f15ab7b49c0920a322cd832413ece7c9948
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRG1 DSCAML1 CADM2 ARFGEF3 PTPRH C12orf42 RIMS2 UNC80	6.07e-07	186	170	8	b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCell	10x5'v1-week_17-19-Lymphocytic_T-T_NK-NK_T_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRAV9-2 ADGRL1 SLC4A10 GPR171 LY9 KLRB1 ARAP2 TRAV13-1	6.32e-07	187	170	8	3301e0fca8c436d136c71f1a8fd59b3bb11bdd83
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRAV9-2 SLF1 ETS1 GPR171 LY9 TRAV38-2DV8 KLRB1 ARAP2	7.42e-07	191	170	8	29ce21c6e810edd51f13e0fb1083cd44bd57b1d4
ToppCell	NS-moderate-d_07-13-Lymphoid-CTL\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SLF1 ETS1 CSF1 SUN2 CD101 GPR171 LY9 KLRB1	7.71e-07	192	170	8	ab2c3d829f5cbf4eb386babcfdf851222a2a88e8
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NRCAM ATP8B1 MYO5C ARFGEF3 STOX2 LRRIQ1 C12orf42 MUC5AC	7.71e-07	192	170	8	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	(07)_Brush\|World / shred by cell type and Timepoint	FLNB NRCAM DSCAML1 STOX2 AVIL AHSG KIT DCLK1	8.02e-07	193	170	8	9af9d22a130ff97a9c37142a65e841b056d08640
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLNB SLF1 ETS1 ATP8B1 LIFR HMCN1 SIPA1L2 KIT	8.34e-07	194	170	8	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	10x5'v1-week_14-16-Lymphocytic_T-T_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRAV9-2 ETS1 TRBV10-3 SLC4A10 GPR171 TRAV38-1 KLRB1 TRAV13-1	9.01e-07	196	170	8	cd23c6a29ead3f3ec23c871e6e30bb8812bf1973
ToppCell	10x5'v1-week_14-16-Lymphocytic_T\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRAV9-2 ETS1 TRBV10-3 SLC4A10 GPR171 TRAV38-1 KLRB1 TRAV13-1	9.01e-07	196	170	8	6fb93466e53a12f8292da29b9e4952d453b913c3
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	OLFML2B TNS2 LIFR SSPN NAV2 PCDH18 PALLD DCLK1	9.36e-07	197	170	8	5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	OLFML2B TNS2 LIFR SSPN NAV2 PCDH18 PALLD DCLK1	9.36e-07	197	170	8	b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	OLFML2B TNS2 LIFR SSPN NAV2 PCDH18 PALLD DCLK1	9.36e-07	197	170	8	1baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	OLFML2B LIFR SSPN CSF1 PCDH18 PALLD DCLK1 CNTN1	1.01e-06	199	170	8	9b2262edbdec89166d895ab97527e0ee5f9b6010
ToppCell	(22)_CD8+_T_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	TRA SLC35A1 ETS1 TMEM171 SLC4A10 GPR171 LY9 KLRB1	1.01e-06	199	170	8	e1261507f0adade3ba534d5b465c9c559fc3aed0
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	OLFML2B LIFR SSPN CSF1 PCDH18 PALLD DCLK1 CNTN1	1.01e-06	199	170	8	251b3643dcd8f4645b17101bd716e66f12a20e88
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	OLFML2B LIFR SSPN CSF1 PCDH18 PALLD DCLK1 CNTN1	1.01e-06	199	170	8	117f4f43b6c06dda553799b1063e827bce697370
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage\|368C / Donor, Lineage, Cell class and subclass (all cells)	ARHGEF28 MUC12 SAMD9L PDE8B CD101 CUZD1 CCL23	2.07e-06	153	170	7	e0fbbfd4d13031412e0b985322c8b99c56eb7af5
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRG1 DSCAML1 ARFGEF3 PTPRH C12orf42 RIMS2 UNC80	2.67e-06	159	170	7	7747cef94c55144fddcd024a7495318357f1351b
ToppCell	10x5'-Lung-Lymphocytic_B-Naive_B_cells\|Lung / Manually curated celltypes from each tissue	IGKV1-39 ATP8B1 IGHD C12orf42 CD72 IGKV1D-39 LY9	3.42e-06	165	170	7	1776e7db80d7cf6b449fa8635a111705a59231b4
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NRG1 DSCAML1 CADM2 FAM83B SLC4A10 RIMS2 UNC80	3.70e-06	167	170	7	c87ebfa8c3284ad33579190e148c95bcaf670d17
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF26B OLFML2B HMCN1 KCNJ1 PDE8B KIT UNC80	3.85e-06	168	170	7	e40a3f85be7e9bb23bfbc1f9cb5e5fc54bb43863
ToppCell	Control\|World / group, cell type (main and fine annotations)	ARHGEF28 MYO5C ARFGEF3 RANBP17 STOX2 NAV2 MUC5AC	3.85e-06	168	170	7	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF26B OLFML2B HMCN1 KCNJ1 PDE8B KIT UNC80	3.85e-06	168	170	7	b1d6c35a5ae69c8638afd68c2be5bc9ce6fd2659
ToppCell	-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	FLNB TRA ETS1 GPR171 LY9 TRAV38-1 KLRB1	4.16e-06	170	170	7	601630644f09133ee4c5e64499460b55cf3e80a0
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBP2 PLEK2 PTPRH ZMYND10 KCNJ10 LY9 TMPRSS7	4.16e-06	170	170	7	a121e10099faaeb60251eec162f38caf7c4238c2
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	NRG1 FLNB MYO5C RANBP17 STOX2 NAV2 MYO16	4.16e-06	170	170	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	Bronchial_Biopsy-Epithelial-Ionocytes\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	NRCAM WDR88 APOB ITPR2 TMEM171 C12orf42 KIT	4.85e-06	174	170	7	7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	NRG1 MYO5C RANBP17 STOX2 NAV2 MYO16 ARAP2	4.85e-06	174	170	7	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBP2 PLEK2 PTPRH ZMYND10 KCNJ10 LY9 TMPRSS7	5.04e-06	175	170	7	f7cd2ef79d91d64976fcdb5f1e7343b24ba27456
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	OLFML2B FAM83B SSPN CSF1 PCDH19 PKP1 DCLK1	5.23e-06	176	170	7	08f94b78b27feeb113dbfadbfa7fe34d08b2809b
ToppCell	facs-MAT-Fat-3m-Lymphocytic-T_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ETS1 BBS9 C12orf42 NAV2 KIT MYO16 CNTN1	5.23e-06	176	170	7	71b3309ddadd035a1224fca4fc5946dc4c0283fe
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAPK8IP1 DRD1 DNAH2 SPAG8 LRRIQ1 CFAP92 ZMYND10	5.63e-06	178	170	7	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	Neuroendocrine-neuroendo-1\|World / Class top	DLL4 TG TMEM171 KCNJ1 DGKK C12orf42 UNC80	6.06e-06	180	170	7	50fdd182a083380899b5943cb5f55ffd77e2a7d4
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NRG1 KIF26B OLFML2B CLUL1 SIPA1L2 KIT PCDH18	6.28e-06	181	170	7	7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a
ToppCell	10x5'-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	IGKV1-39 IGLV3-10 IGHD C12orf42 CD72 IGKV1D-39 LY9	6.51e-06	182	170	7	310f94437d197eaaaf6e30e68063b33e94befe77
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NRCAM ATP8B1 TRPM3 KCNJ15 DOCK7 TLN2 MYO16	6.51e-06	182	170	7	f96095b81188b52db8fcfca4837129cfcd9bd7b7
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	NRG1 NRCAM KIAA1549 DSCAML1 STOX2 TRPM3 KCNJ15	7.00e-06	184	170	7	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TTC16 ETS1 SLC4A10 GPR171 LY9 KLRB1 TRAV13-1	7.51e-06	186	170	7	b099cb0902e9afb11218d70407d3cab212343c6d
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLNB DLL4 TIAM2 HMCN1 TLN2 PALLD DCLK1	7.51e-06	186	170	7	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	NRG1 MYO5C RANBP17 STOX2 NAV2 MYO16 ARAP2	7.51e-06	186	170	7	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	ILEUM-inflamed-(1)_CD8_Trm\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TRA SLC35A1 ETS1 MSH3 GPR171 KLRB1 ARAP2	7.78e-06	187	170	7	a77d7ae44f47410bd92fb3aa0f44dce891752b63
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ETS1 CCDC168 SLC4A10 GPR171 LY9 KIT KLRB1	7.78e-06	187	170	7	f31d865ce2a21bdf64dbe29ee3e4505ab482604a
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	NRG1 MYO5C RANBP17 STOX2 MYO16 GAB1 ARAP2	7.78e-06	187	170	7	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	NRG1 FAM83B ARFGEF3 STOX2 PKP1 PLXNB1 SPINK5	7.78e-06	187	170	7	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	COVID-19-kidney-CD-PC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRCAM ARHGEF10L FAM83B TRPM3 KCNJ1 MID1 KCNJ15	8.05e-06	188	170	7	8f9996c3f3b27efaaae8960a66af77412de9c7ef
ToppCell	10x5'v1-week_14-16-Lymphocytic_T-T_NK-CD8_T_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRAV9-2 TTC16 ETS1 TRBV10-3 GPR171 KLRB1 TRAV13-1	8.33e-06	189	170	7	347dea83d0c612341c1ef6e5df5e369520f0a0a4
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	NRG1 FLNB ETS1 ATP8B1 ITPR2 HMCN1 TRPM3	8.33e-06	189	170	7	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	NRG1 FLNB ETS1 ATP8B1 ITPR2 HMCN1 TRPM3	8.33e-06	189	170	7	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF28 NRCAM MYO5C ARFGEF3 STOX2 LRRIQ1 ARAP2	8.33e-06	189	170	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NRCAM KIF26B ATP8B1 ARHGEF10L TRPM3 KCNJ15 DOCK7	8.33e-06	189	170	7	c9565e962a13a7713056ec3dbb1b67d24f9889c7
ToppCell	10x5'v1-week_14-16-Lymphocytic_T-T_NK-CD4_T_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRAV9-2 ETS1 TRBV10-3 GPR171 TRAV38-1 KLRB1 TRAV13-1	8.63e-06	190	170	7	8fdf35c2ad1d325c00c00e4fcf2506341ff14537
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FLNB DSCAML1 ARFGEF3 PDE8B SLC4A10 RIMS2 UNC80	8.63e-06	190	170	7	b5c6f3248c0c2f648e1578457c6a729ca22bf0da
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TRGV3 ETS1 SLC4A10 GPR171 LY9 KLRB1 ARAP2	8.63e-06	190	170	7	326002d7f9de5e425cee76d9a0277f42d79058e2
ToppCell	10x5'v1-week_14-16-Lymphocytic_T-T_NK-Treg\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRAV9-2 ETS1 TRBV10-1 PKP1 GPR171 KLRB1 TRAV13-1	8.63e-06	190	170	7	8540f4dee99280109e38b997d9247b176808c51a
ToppCell	5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NRCAM DLL4 ARHGEF10L ITPR2 AVIL ZFHX3 KIT	8.93e-06	191	170	7	54f07e4de61735051498846afb44b1798bed8144
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	OLFML2B TNS2 LIFR TMEM171 SSPN CNTN1 SMAD9	8.93e-06	191	170	7	98b907f8fa024cf32e462323b782c5a371327bbd
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	NRG1 FLNB ITPR2 HMCN1 TRPM3 SIPA1L1 SMAD9	9.23e-06	192	170	7	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	critical-Lymphoid-CTL\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SLF1 ETS1 SUN2 CD101 GPR171 LY9 KLRB1	9.23e-06	192	170	7	8c83050c1578d43ca0398ff920f30ea63f092a83
ToppCell	ILEUM-non-inflamed-(1)_CD8_Trm\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TRA SLC35A1 ETS1 MSH3 GPR171 KLRB1 ARAP2	9.23e-06	192	170	7	a9f89043c97cd2b0ba165e69ee5681094410af37
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TRGV3 ETS1 SLC4A10 GPR171 LY9 KLRB1 ARAP2	9.55e-06	193	170	7	52f42ec293a5077a44de5c27e89b57c23944e560
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLNB SLF1 ETS1 ATP8B1 LIFR HMCN1 KIT	9.55e-06	193	170	7	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DLL4 KIF26B ETS1 ATP8B1 LIMK2 SIPA1L2 KIT	9.55e-06	193	170	7	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TRGV3 ETS1 TRBV10-2 LY9 TRAV38-2DV8 KLRB1 ARAP2	9.55e-06	193	170	7	bae37ec161fad7c91edc674a2c7808b51c9a8135
ToppCell	10x5'v1-week_12-13-Lymphocytic_T-T_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRAV9-2 TTC16 ETS1 GPR171 LY9 KLRB1 TRAV13-1	9.88e-06	194	170	7	b1ed9b7ea9298dc3ce900a2c6b0a2ca6412f1f5f
ToppCell	10x5'v1-week_12-13-Lymphocytic_T\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRAV9-2 TTC16 ETS1 GPR171 LY9 KLRB1 TRAV13-1	9.88e-06	194	170	7	4abc925820d23793d6ebf83fd7df8e75b32f09b4
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRG1 NRCAM TRPM3 TRIM9 SLC4A10 RIMS2 DCLK1	1.02e-05	195	170	7	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	TTC16 ETS1 ADGRL1 PLEKHG3 DGKK KLRB1 ARAP2	1.02e-05	195	170	7	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	(1)_T_CD8_activated\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SLF1 TRA SLC35A1 ETS1 GPR171 CCL23 ARAP2	1.02e-05	195	170	7	2253590339b87692d350f9ea3d2aa851179967e1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TTC16 ETS1 ADGRL1 PLEKHG3 DGKK KLRB1 ARAP2	1.06e-05	196	170	7	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTC16 ETS1 ADGRL1 PLEKHG3 DGKK KLRB1 ARAP2	1.06e-05	196	170	7	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	droplet-Tongue-nan-3m-Epithelial-parabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 FLNB FBP2 SUN2 AVIL PCDH19 PALLD	1.06e-05	196	170	7	159061fd0961b2cfb5941d403acc5b395dd0d3a0
ToppCell	(1)_T_CD8_MAIT\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	TRA SLC35A1 TMEM171 SUN2 SLC4A10 GPR171 KLRB1	1.06e-05	196	170	7	5fc99a8e3dde12fd0b0b2e0a2db48ac16b42739e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TTC16 ETS1 ADGRL1 PLEKHG3 DGKK KLRB1 ARAP2	1.06e-05	196	170	7	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTC16 ETS1 ADGRL1 PLEKHG3 DGKK KLRB1 ARAP2	1.06e-05	196	170	7	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRAV9-2 ETS1 SLC4A10 GPR171 LY9 KLRB1 TRAV13-1	1.09e-05	197	170	7	4bc76958ca12af2dd490d4865de6a92554a14656
ToppCell	Mild_COVID-19-T/NK-CD4+_T_1\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	TRAV9-2 ETS1 SLC4A10 GPR171 KLRB1 MYO16 TRAV13-1	1.09e-05	197	170	7	98fca0a2e2f66525c5c9d6cdaebcad14b4d53da4
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV3 TRBV10-1 SLC4A10 GPR171 LY9 KLRB1 TRAV13-1	1.09e-05	197	170	7	53b20c439b9473b49011cd175d2770f12c472fc3
ToppCell	Sepsis-Bac-SEP-Lymphocyte-T/NK-MAIT\|Bac-SEP / Disease, condition lineage and cell class	ETS1 SLC4A10 GPR171 LY9 KLRB1 PLXNB1 TRAV13-1	1.13e-05	198	170	7	aea3654b16785aa9857ed646bd0d0dc9724df364
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLF1 NRCAM SLC4A10 RIMS2 DCLK1 UNC80 CNTN1	1.13e-05	198	170	7	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	(220)_CD8+_Cytotoxic_T_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	TTC16 TRA SLC35A1 TMEM171 SLC4A10 GPR171 KLRB1	1.13e-05	198	170	7	2af389b8ea5767ba56fe64d719afe5be3f9a43ec
ToppCell	stromal_cell-stromal_cell\|World / Lineage and Cell class	OLFML2B TNS2 APOB LIFR NAV2 PCDH18 DCLK1	1.17e-05	199	170	7	74262363a34da3a1eb55ab375fd61ddd7bb39b23
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV3 TRBV10-1 SLC4A10 GPR171 LY9 KLRB1 TRAV13-1	1.17e-05	199	170	7	f53190b7e236b46a7ffca52977b9ad39831f66f4
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OLFML2B CADM2 LIMK2 SSPN SIPA1L2 GPR176 PALLD	1.17e-05	199	170	7	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OLFML2B CADM2 LIMK2 SSPN SIPA1L2 GPR176 PALLD	1.17e-05	199	170	7	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	stromal_cell\|World / Lineage and Cell class	OLFML2B TNS2 APOB LIFR NAV2 PCDH18 DCLK1	1.17e-05	199	170	7	507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ETS1 TMEM171 SLC4A10 GPR171 LY9 KLRB1 ARAP2	1.17e-05	199	170	7	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DRD1 OLFML2B PLEKHG3 PDE8B ZFHX3 PCDH18 CNTN1	1.20e-05	200	170	7	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	NRCAM OLFML2B ETS1 TNS2 PLEKHG3 PDE8B PCDH18	1.20e-05	200	170	7	0c648941447c738caf62f2d71e296d6cca492c8b
Drug	Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A	SARM1 ADGRL1 CBL ITPR2 LIFR MTMR3 PKP1 RND2 HAO2 GPR176	1.06e-06	195	157	10	3401_UP
Drug	CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A	APOB CBL LIMK2 CSF1 PTPRH TRPM3 KCNJ15 TLN2 MUC5AC GAB1	1.06e-06	195	157	10	4557_UP
Drug	Proxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	VLDLR DRD1 CTC1 SUN1 TNS2 ARHGEF10L PDE8B NFX1 TLN2 SPINK5	1.16e-06	197	157	10	5993_DN
Drug	Apramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	SUN1 ITPR2 ZNF277 PDE8B SUN2 SIPA1L1 MID1 MTMR3 GAB1 SPINK5	1.16e-06	197	157	10	7334_UP
Drug	Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A	VLDLR ERCC6 CBL ZNF277 PLEKHG3 PDE8B MTMR3 RIMS2 GAB1	8.40e-06	194	157	9	6068_DN
Drug	tetraethylenepentamine pentahydrochloride; Down 200; 100uM; HL60; HG-U133A	FLNB VEZT TG PLEK2 TRPM3 PDE8B RIMS2 CNTN1 PHLPP2	9.13e-06	196	157	9	412_DN
Drug	Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	OLFML2B SUN1 ADGRL1 SPAG8 SSPN MED25 TLN2 RIMS2 GAB1	9.51e-06	197	157	9	4120_UP
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	NRCAM MSH3 ITPR2 ZNF277 PDE8B SIPA1L1 MED25 KLRB1 GAB1	9.51e-06	197	157	9	6198_UP
Drug	Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A	SPAG8 TG TRPM3 PLEKHG3 KCNJ1 AVIL PKP1 TLN2 LY9	9.51e-06	197	157	9	5249_UP
Drug	Flumequine [42835-25-6]; Up 200; 15.4uM; PC3; HT_HG-U133A	VEZT KIF26B SARM1 SPAG8 ANGEL2 MTMR3 CD72 RND2 GAB1	9.90e-06	198	157	9	5104_UP
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; PC3; HT_HG-U133A	NRG1 VLDLR OLFML2B LIMK2 KCNJ1 PDE8B CD101 ZFHX3 LY9	9.90e-06	198	157	9	4252_DN
Drug	Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SARM1 CBL ITPR2 TG SSPN PDE8B MTMR3 RIMS2 HAO2	1.03e-05	199	157	9	4840_UP
Drug	Deptropine citrate [2169-75-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A	KCNJ10 CD101 MID1 MED25 RIMS2 MUC5AC GPR176 INVS SPINK5	1.03e-05	199	157	9	5543_UP
Drug	Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	VLDLR CBL SSPN CSF1 SH3TC1 PLEKHG3 PDE8B MID1 SPINK5	1.03e-05	199	157	9	3349_DN
Drug	Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; MCF7; HT_HG-U133A	VEZT SUN1 SPAG8 LIMK2 SSPN MTMR3 AHSG RND2 RIMS2	1.03e-05	199	157	9	3224_UP
Drug	AC1L3ZYH	MID1 KLRB1	4.72e-05	2	157	2	CID000149947
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A	NRG1 FLNB DRD1 SH3TC1 SIPA1L1 MED25 PKP1 CD72	4.99e-05	188	157	8	3046_UP
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	SARM1 LIMK2 SUN2 ANGEL2 MED25 CUZD1 APPL1 GPR176	6.00e-05	193	157	8	3677_DN
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A	ITPR2 TG ANGEL2 MED25 TLN2 CLUL1 KIT MUC5AC	6.00e-05	193	157	8	6678_UP
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	VLDLR SH3TC1 PLEKHG3 ANGEL2 NFX1 MED25 RND2 GAB1	6.22e-05	194	157	8	3422_UP
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; MCF7; HT_HG-U133A	SUN1 ADGRL1 ARHGEF10L LIMK2 SUN2 MTMR3 TLN2 RND2	6.22e-05	194	157	8	5998_DN
Drug	0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A	ERCC6 DRG2 VEZT SARM1 NTSR1 ARHGEF10L MED25 PKP1	6.22e-05	194	157	8	7098_DN
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A	SARM1 BBS9 SH3TC1 ZNF277 PLEKHG3 NFX1 MED25 CNTN1	6.45e-05	195	157	8	3737_DN
Drug	Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; PC3; HT_HG-U133A	NRG1 CSF1 SH3TC1 TRPM3 MTMR3 CLUL1 RIMS2 INVS	6.45e-05	195	157	8	6692_UP
Drug	AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A	SARM1 NTSR1 TNS2 BBS9 PTPRH PLEKHG3 NFX1 ZFHX3	6.45e-05	195	157	8	6557_UP
Drug	Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A	CTC1 SARM1 ADGRL1 LIMK2 SUN2 MTMR3 TLN2 GAB1	6.45e-05	195	157	8	7372_UP
Drug	Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	NRG1 ADGRL1 LIMK2 PDE8B CUZD1 RIMS2 KIT GAB1	6.69e-05	196	157	8	6483_UP
Drug	Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	VLDLR ERCC6 OLFML2B SPAG8 ZNF277 KCNJ15 CNTN1 SPINK5	6.69e-05	196	157	8	6785_UP
Drug	Sulfachloropyridazine [80-32-0]; Up 200; 14uM; HL60; HT_HG-U133A	ADGRL1 TNS2 RANBP17 PDE8B SIPA1L1 AVIL ANGEL2 GPR171	6.93e-05	197	157	8	2191_UP
Drug	Enalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A	ADGRL1 BBS9 SH3TC1 KCNJ1 CUZD1 MTMR3 RIMS2 MUC5AC	6.93e-05	197	157	8	7026_UP
Drug	Chlormezanone [80-77-3]; Up 200; 14.6uM; PC3; HT_HG-U133A	NRG1 VLDLR SARM1 BBS9 LIFR SH3TC1 ANGEL2 GAB1	6.93e-05	197	157	8	4636_UP
Drug	Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A	SARM1 ITPR2 TG SH3TC1 CD101 TLN2 LY9 SPINK5	6.93e-05	197	157	8	2809_UP
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; HL60; HT_HG-U133A	DRD1 DNAH2 ITPR2 TG MED25 AHSG RIMS2 PALLD	6.93e-05	197	157	8	3063_UP
Drug	Ifosfamide [3778-73-2]; Up 200; 15.4uM; MCF7; HT_HG-U133A	SUN1 LIMK2 PDE8B SIPA1L1 CUZD1 HAO2 CNTN1 SPINK5	6.93e-05	197	157	8	6279_UP
Drug	Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; PC3; HT_HG-U133A	NRG1 NRCAM KIF26B CSF1 ZMYND10 PLEKHG3 MED25 RIMS2	7.18e-05	198	157	8	6648_UP
Drug	Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; PC3; HT_HG-U133A	VLDLR APOB ITPR2 CD72 CLUL1 CCL23 INVS SMAD9	7.18e-05	198	157	8	5044_UP
Drug	Phenelzine sulfate [156-51-4]; Up 200; 17uM; MCF7; HT_HG-U133A	VEZT SUN1 SARM1 MID1 KCNJ15 MED25 MTMR3 ZW10	7.18e-05	198	157	8	3884_UP
Drug	Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	VLDLR OLFML2B ADGRL1 BBS9 SSPN MTMR3 RND2 RIMS2	7.18e-05	198	157	8	6786_UP
Drug	Dichlorphenamide [120-97-8]; Up 200; 13.2uM; HL60; HT_HG-U133A	DRD1 CTC1 ITPR2 PLEK2 MED25 AHSG ZFHX3 KIT	7.18e-05	198	157	8	3027_UP
Drug	ICI 182,780; Up 200; 0.01uM; PC3; HT_HG-U133A	ETS1 SPAG8 PLEKHG3 KCNJ15 MED25 MUC5AC HAO2 GAB1	7.18e-05	198	157	8	4462_UP
Drug	Proglumide [6620-60-6]; Up 200; 12uM; PC3; HT_HG-U133A	NRCAM OLFML2B SARM1 ITPR2 PLEKHG3 NFX1 MUC5AC PHLPP2	7.44e-05	199	157	8	4337_UP
Drug	Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A	ADGRL1 TNS2 MSH3 LIMK2 SUN2 SIPA1L1 KCNJ15 GAB1	7.44e-05	199	157	8	6097_DN
Drug	Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; PC3; HT_HG-U133A	SARM1 ADGRL1 BBS9 LIMK2 PTPRH CD101 MED25 CUZD1	7.44e-05	199	157	8	6336_UP
Drug	valinomycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	SPAG8 ITPR2 MID1 MED25 LY9 RIMS2 CNTN1 SPINK5	7.44e-05	199	157	8	5906_DN
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; PC3; HT_HG-U133A	APOB CBL MTMR3 PKP1 TLN2 KIT MUC5AC GAB1	7.44e-05	199	157	8	6660_UP
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	ADGRL1 CSF1 ANGEL2 MED25 MTMR3 LY9 RIMS2 SPINK5	7.44e-05	199	157	8	5540_UP
Drug	Trolox [53188-07-1]; Up 200; 16uM; MCF7; HT_HG-U133A	VEZT OLFML2B ZMYND10 ANGEL2 KLRB1 GPR176 ARAP2 PHLPP2	7.44e-05	199	157	8	6007_UP
Drug	Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	ERCC6 SUN1 BBS9 ZNF277 PDE8B SIPA1L1 AHSG KIT	7.44e-05	199	157	8	6775_UP
Drug	Aminocaproic acid [60-32-2]; Down 200; 30.4uM; PC3; HT_HG-U133A	BRIP1 DRG2 SUN1 TNS2 BBS9 POLR1B ARAP2 INVS	7.44e-05	199	157	8	7258_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A	DRD1 SPAG8 CSF1 PDE8B MID1 MUC5AC GAB1 CNTN1	7.44e-05	199	157	8	4995_UP
Drug	Carcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A	VEZT ITPR2 MID1 NFX1 MED25 RND2 RIMS2 KLRB1	7.70e-05	200	157	8	4809_UP
Drug	triiodide	TG TRIM9 MID1	2.43e-04	18	157	3	CID000105054
Drug	ammonium lactate	NTSR1 SPINK5	2.81e-04	4	157	2	CID000062358
Drug	Emetine dihydrochloride [316-42-7]; Down 200; 7.2uM; PC3; HT_HG-U133A	SUN1 NTSR1 ADGRL1 SPAG8 KCNJ1 MED25 PLXNB1	2.86e-04	183	157	7	4243_DN
Drug	Azacytidine-5 [320-67-2]; Up 200; 16.4uM; PC3; HT_HG-U133A	NRG1 KCNJ15 MED25 TLN2 KLRB1 GAB1 SPINK5	3.36e-04	188	157	7	4010_UP
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	BRIP1 CTC1 SUN1 CBL LIMK2 NFX1 MUC5AC	3.59e-04	190	157	7	7528_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A	DRD1 ITPR2 SSPN CSF1 CUZD1 NAV2 RIMS2	3.59e-04	190	157	7	3966_DN
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	ADGRL1 CBL CSF1 ANGEL2 NAV2 TLN2 RIMS2	3.70e-04	191	157	7	6479_UP
Drug	Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ZNF277 CD101 NFX1 CUZD1 LY9 KLRB1 GPR176	3.70e-04	191	157	7	6498_UP
Drug	Propofol [2078-54-8]; Down 200; 22.4uM; MCF7; HT_HG-U133A	VEZT SUN1 SSPN SUN2 ANGEL2 NFX1 SPINK5	3.70e-04	191	157	7	3386_DN
Drug	Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A	VLDLR ANGEL2 MED25 NAV2 MUC5AC PALLD CNTN1	3.82e-04	192	157	7	1696_UP
Drug	Ergocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A	NRG1 SUN1 HPSE SH3TC1 SIPA1L1 MED25 ZFHX3	3.82e-04	192	157	7	2572_UP
Drug	cyclosporine A; Up 200; 1uM; MCF7; HG-U133A	MSH3 ARHGEF10L CD101 MTMR3 TLN2 RIMS2 GAB1	3.82e-04	192	157	7	602_UP
Drug	Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; HL60; HT_HG-U133A	NRG1 SPAG8 KCNJ1 MED25 AHSG CD72 RIMS2	3.82e-04	192	157	7	2738_UP
Drug	Cefalonium [5575-21-3]; Up 200; 8.8uM; MCF7; HT_HG-U133A	BBS9 LIMK2 CSF1 ANGEL2 RND2 PLXNB1 GAB1	3.94e-04	193	157	7	7341_UP
Drug	thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	ARHGEF10L SSPN CSF1 SH3TC1 MED25 HAO2 PALLD	3.94e-04	193	157	7	6189_UP
Drug	Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A	APOB TRPM3 PDE8B KCNJ15 RND2 LY9 MUC5AC	3.94e-04	193	157	7	2283_UP
Drug	Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A	TNS2 SPAG8 ZNF277 PLEKHG3 KCNJ1 MED25 ZFHX3	3.94e-04	193	157	7	6733_DN
Drug	Trichlormethiazide [133-67-5]; Up 200; 10.6uM; HL60; HT_HG-U133A	SARM1 ITPR2 SSPN CSF1 SH3TC1 MED25 GAB1	4.07e-04	194	157	7	2998_UP
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	BBS9 LIMK2 PLEKHG3 CD101 NFX1 TLN2 ZFHX3	4.07e-04	194	157	7	3674_DN
Drug	Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; PC3; HT_HG-U133A	SARM1 PTPRH ZNF277 NFX1 TLN2 KLRB1 GPR176	4.07e-04	194	157	7	5091_UP
Drug	6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; PC3; HT_HG-U133A	NRG1 NTSR1 TNS2 SPAG8 KCNJ1 LY9 PLXNB1	4.19e-04	195	157	7	4250_DN
Drug	Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; MCF7; HT_HG-U133A	LIMK2 CSF1 TRIM9 ZNF277 ANGEL2 MED25 MTMR3	4.19e-04	195	157	7	5676_UP
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A	DRD1 LIMK2 ZNF277 PDE8B MID1 MTMR3 PLXNB1	4.19e-04	195	157	7	4373_DN
Drug	Probucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	DRD1 VEZT TNS2 SPAG8 SSPN NFX1 MTMR3	4.19e-04	195	157	7	5626_DN
Drug	Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ARHGEF28 ADGRL1 TG SSPN CSF1 KCNJ15 GAB1	4.32e-04	196	157	7	4119_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A	TNS2 CBL BBS9 ITPR2 SUN2 NFX1 ZW10	4.32e-04	196	157	7	3633_DN
Drug	Kaempferol [520-18-3]; Up 200; 14uM; MCF7; HT_HG-U133A	FLNB CTC1 SIPA1L1 MID1 NAV2 GAB1 CNTN1	4.32e-04	196	157	7	3579_UP
Drug	Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; PC3; HT_HG-U133A	BBS9 PTPRH SH3TC1 ZNF277 CD101 NFX1 TLN2	4.32e-04	196	157	7	3702_DN
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Up 200; 12uM; MCF7; HT_HG-U133A	ARHGEF28 CBL BBS9 ITPR2 NFX1 RND2 RIMS2	4.32e-04	196	157	7	3530_UP
Drug	Aminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A	ARHGEF28 CSF1 PLEKHG3 ANGEL2 RIMS2 KIT HAO2	4.32e-04	196	157	7	6453_UP
Drug	Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A	FLNB ADGRL1 HPSE MTMR3 TLN2 RND2 PLXNB1	4.32e-04	196	157	7	1679_DN
Drug	Dimethadione [695-53-4]; Up 200; 31uM; HL60; HT_HG-U133A	DRD1 SARM1 PLEK2 AHSG CD72 ZFHX3 RIMS2	4.32e-04	196	157	7	3029_UP
Drug	Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A	VEZT BBS9 ITPR2 RANBP17 TLN2 ZFHX3 PLXNB1	4.32e-04	196	157	7	4587_DN
Drug	Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; PC3; HT_HG-U133A	SPAG8 TG CSF1 TRPM3 KCNJ15 MED25 CCL23	4.32e-04	196	157	7	6704_UP
Drug	radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A	BRIP1 NRCAM SARM1 PDE8B CUZD1 AHSG ZW10	4.32e-04	196	157	7	5947_DN
Drug	Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ARHGEF28 SARM1 AVIL CCL23 KLRB1 PLXNB1 CNTN1	4.32e-04	196	157	7	3208_UP
Drug	Tinidazole [19387-91-8]; Up 200; 16.2uM; PC3; HT_HG-U133A	NRCAM SPAG8 AHSG TLN2 KIT MUC5AC KLRB1	4.32e-04	196	157	7	4548_UP
Drug	Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A	NRG1 SPAG8 KCNJ1 MED25 ZFHX3 LY9 PLXNB1	4.32e-04	196	157	7	4238_DN
Drug	clozapine; Up 200; 10uM; PC3; HT_HG-U133A	NRG1 SPAG8 CSF1 MED25 AHSG CLUL1 HAO2	4.32e-04	196	157	7	4453_UP
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A	ADGRL1 CBL BBS9 CSF1 ZFHX3 RIMS2 GAB1	4.32e-04	196	157	7	3842_DN
Drug	Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; PC3; HT_HG-U133A	NRCAM TG CSF1 PTPRH ZMYND10 PDE8B LY9	4.32e-04	196	157	7	5112_UP
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; PC3; HT_HG-U133A	NRCAM CSF1 ZNF277 CD72 RIMS2 HAO2 SPINK5	4.32e-04	196	157	7	4075_UP
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; PC3; HT_HG-U133A	OLFML2B LIMK2 PTPRH KCNJ1 NFX1 MED25 PLXNB1	4.32e-04	196	157	7	4254_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ADGRL1 TNS2 BBS9 ITPR2 PLEKHG3 ZW10 PHLPP2	4.32e-04	196	157	7	2225_DN
Drug	Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; PC3; HT_HG-U133A	NRG1 ITPR2 KCNJ15 TLN2 RIMS2 KIT PHLPP2	4.32e-04	196	157	7	3994_UP
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A	ETS1 CBL LIMK2 AVIL MED25 KIT SPINK5	4.32e-04	196	157	7	4317_UP
Drug	Gelsemine [509-15-9]; Up 200; 12.4uM; PC3; HT_HG-U133A	OLFML2B SARM1 ITPR2 TRPM3 ZNF277 PLEKHG3 MTMR3	4.46e-04	197	157	7	4097_UP
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	NRG1 RANBP17 PLEKHG3 KCNJ1 PDE8B MED25 CCL23	4.46e-04	197	157	7	2704_DN
Drug	Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	ZNF280D TNS2 CBL BBS9 ITPR2 MTMR3 TLN2	4.46e-04	197	157	7	7484_UP
Disease	Malignant neoplasm of breast	NRG1 FLNB BRIP1 ERCC6 PNLIPRP1 NRCAM DLL4 WDR88 ATP8B1 HPSE SGK3 CSF1 ZNF277 KCNJ1 SIPA1L1 KCNJ15 MTMR3 APPL1 CLUL1 KIT PLXNB1 GAB1	4.56e-08	1074	154	22	C0006142
Disease	orofacial cleft, sex interaction measurement	NRCAM ETS1 TMEM171 SSPN ZFHX3	8.99e-05	86	154	5	EFO_0008343, MONDO_0000358
Disease	nephrotic syndrome (biomarker_via_orthology)	VLDLR APOB KCNJ1	2.60e-04	24	154	3	DOID:1184 (biomarker_via_orthology)
Disease	mucinous adenocarcinoma (is_marker_for)	ZFHX3 MUC5AC	2.68e-04	5	154	2	DOID:3030 (is_marker_for)
Disease	Drug habituation	NRCAM TIAM2 MYO5C PRPF4 TMPRSS7	3.51e-04	115	154	5	C0013170
Disease	Drug abuse	NRCAM TIAM2 MYO5C PRPF4 TMPRSS7	3.51e-04	115	154	5	C0013146
Disease	Prescription Drug Abuse	NRCAM TIAM2 MYO5C PRPF4 TMPRSS7	3.51e-04	115	154	5	C4316881
Disease	Substance-Related Disorders	NRCAM TIAM2 MYO5C PRPF4 TMPRSS7	3.51e-04	115	154	5	C0236969
Disease	Drug Use Disorders	NRCAM TIAM2 MYO5C PRPF4 TMPRSS7	3.51e-04	115	154	5	C0013222
Disease	Drug Dependence	NRCAM TIAM2 MYO5C PRPF4 TMPRSS7	3.51e-04	115	154	5	C1510472
Disease	Substance Dependence	NRCAM TIAM2 MYO5C PRPF4 TMPRSS7	3.51e-04	115	154	5	C0038580
Disease	Substance Use Disorders	NRCAM TIAM2 MYO5C PRPF4 TMPRSS7	3.51e-04	115	154	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	NRCAM TIAM2 MYO5C PRPF4 TMPRSS7	3.51e-04	115	154	5	C0029231
Disease	Substance abuse problem	NRCAM TIAM2 MYO5C PRPF4 TMPRSS7	3.65e-04	116	154	5	C0740858
Disease	protocadherin-10 measurement	NRG1 SARM1	4.00e-04	6	154	2	EFO_0801978
Disease	Opitz GBBB syndrome (implicated_via_orthology)	TRIM9 MID1	4.00e-04	6	154	2	DOID:0080697 (implicated_via_orthology)
Disease	solute carrier family 35 member G2 measurement	NRG1 SARM1	4.00e-04	6	154	2	EFO_0802080
Disease	sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) measurement	NRG1 SARM1	5.59e-04	7	154	2	EFO_0803304
Disease	MASA syndrome (implicated_via_orthology)	NRCAM TRPM3	5.59e-04	7	154	2	DOID:0060246 (implicated_via_orthology)
Disease	E3 ubiquitin-protein ligase RNF13 measurement	NRG1 SARM1	7.42e-04	8	154	2	EFO_0801556
Disease	CD27 antigen measurement	NRG1 SARM1	7.42e-04	8	154	2	EFO_0008078
Disease	common bile duct neoplasm (is_marker_for)	APOB MUC5AC	7.42e-04	8	154	2	DOID:4608 (is_marker_for)
Disease	alcohol consumption measurement	ZNF280D DNAH2 DPP3 CADM2 RANBP17 STOX2 KCNJ10 SLC4A10 WDR82 ZFHX3 ZW10 RIMS2 KIT DCLK1 ARAP2 PHLPP2	8.09e-04	1242	154	16	EFO_0007878
Disease	beta-1,4-glucuronyltransferase 1 measurement	NRG1 IGHD	9.51e-04	9	154	2	EFO_0801412
Disease	tumor necrosis factor receptor superfamily member 16 measurement	SARM1 IGHD	9.51e-04	9	154	2	EFO_0802168
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	SARM1 APOB DOCK7 AHSG	1.09e-03	86	154	4	EFO_0008595, EFO_0020945
Disease	WNT1-inducible-signaling pathway protein 1 measurement	SARM1 TG	1.18e-03	10	154	2	EFO_0008321
Disease	alpha wave measurement, electroencephalogram measurement	CD72 CLUL1	1.18e-03	10	154	2	EFO_0004357, EFO_0006870
Disease	Colorectal Carcinoma	ERCC6 NRCAM APOB DSCAML1 ARHGEF10L LIFR SH3TC1 DCLK1 CNTN1 ANAPC4 SMAD9	1.19e-03	702	154	11	C0009402
Disease	autism spectrum disorder (implicated_via_orthology)	ZNF280D NRCAM DSCAML1 PKP1 RIMS2	1.24e-03	152	154	5	DOID:0060041 (implicated_via_orthology)
Disease	pneumococcal bacteremia	CFAP92 DOCK7	1.44e-03	11	154	2	EFO_1001925
Disease	gastrin-releasing peptide measurement	NRG1 SARM1	1.44e-03	11	154	2	EFO_0022000
Disease	persulfide dioxygenase ETHE1, mitochondrial measurement	NRG1 SARM1	1.73e-03	12	154	2	EFO_0008258
Disease	microphthalmia (implicated_via_orthology)	TRPM3 MID1	1.73e-03	12	154	2	DOID:10629 (implicated_via_orthology)
Disease	dementia (is_implicated_in)	NRG1 VLDLR	1.73e-03	12	154	2	DOID:1307 (is_implicated_in)
Disease	transmembrane protein 87B measurement	NRG1 SARM1	2.03e-03	13	154	2	EFO_0802158
Disease	brain measurement, neuroimaging measurement	SLF1 KIF26B BBS9 DSCAML1 TG LRRIQ1 SLC4A10 NAV2 ZFHX3	2.48e-03	550	154	9	EFO_0004346, EFO_0004464
Disease	coronary artery calcification	NRG1 PNLIPRP1 APOB CADM2 TRIM9 SIPA1L1 DOCK7 CCL23	2.59e-03	450	154	8	EFO_0004723
Disease	semaphorin-3A measurement	NRG1 SARM1	2.72e-03	15	154	2	EFO_0008278
Disease	SLAM family member 7 measurement	SARM1 LY9	3.50e-03	17	154	2	EFO_0008287
Disease	sphingomyelin 14:0 measurement	TRPM3 ZFHX3	3.50e-03	17	154	2	EFO_0010390
Disease	respiratory symptom change measurement, response to placebo	BBS9 NAV2	3.50e-03	17	154	2	EFO_0008344, EFO_0010068
Disease	glycoprotein measurement	APOB DOCK7 AHSG ZFHX3	3.56e-03	119	154	4	EFO_0004555
Disease	Age-related macular degeneration	ERCC6 HMCN1	3.92e-03	18	154	2	cv:C0242383
Disease	smooth surface dental caries	BBS9 ITPR2 SIPA1L2	4.21e-03	62	154	3	EFO_0006339
Disease	osteochondrodysplasia (is_implicated_in)	FLNB LIFR	4.37e-03	19	154	2	DOID:2256 (is_implicated_in)
Disease	Chronic myeloproliferative disorder	KIT PCNT	4.37e-03	19	154	2	C1292778
Disease	hippocampal tail volume	STOX2 SLC4A10	4.37e-03	19	154	2	EFO_0009398
Disease	unipolar depression, response to bupropion, mood disorder	STOX2 SSPN	4.37e-03	19	154	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	maximal midexpiratory flow rate	BRIP1 MYO16	4.83e-03	20	154	2	EFO_0004313
Disease	heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer	DNAH2 ZFHX3	4.83e-03	20	154	2	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992
Disease	QRS duration	NRG1 OLFML2B HMCN1 SIPA1L1 PALLD CNTN1	4.87e-03	298	154	6	EFO_0005055

Protein segments in the cluster

Peptide	Gene	Start	Entry
QVCNYRSSSFSDVET	ZNF280D	421	Q6N043
SSIVSSIEFDRDCDY	COP1	421	Q8NHY2
NSEVKYTEACSSSSV	FAM200B	11	P0CF97
YTEACSSSSVESGIV	FAM200B	16	P0CF97
ESTDIGSCTTLLVYV	FAM200B	231	P0CF97
YSSVDTGTQCLVSCR	ARHGEF10L	906	Q9HCE6
SLLESYFETNSECSK	CCL23	66	P55773
DSSQDEQSCAAIYTT	AVIL	66	O75366
TGTYSTRLDEQCSAI	ANAPC4	686	Q9UJX5
LSCLSIRESEYSSSL	CTC1	1196	Q2NKJ3
SVLYQSDLDESESCT	ADGRL1	1351	O94910
NRATCYTDLSTDTFV	DLL4	491	Q9NR61
SESEYSTVEECFQSL	ARAP2	411	Q8WZ64
ITSFYQSTSECDVEE	CFAP92	21	Q9ULG3
CETLSSKLATFSEIY	CD72	261	P21854
ETIDNCDSSLSRTYA	DRD1	181	P21728
EVTTCHSRSAITVDY	ANGEL2	466	Q5VTE6
EETYIDLTTESPSSC	CASP8AP2	1791	Q9UKL3
KEYRSVLDDLTSCTT	ERCC6	131	Q03468
SSSEPNSLCYVETAE	ATP8B1	216	O43520
DTVVSSSCCTSLDYI	RANBP17	926	Q9H2T7
QLTEASSATSKAYCV	ITPR2	1866	Q14571
SKLVLRCETSSEYSS	NRG1	51	Q02297
EFSSLLSLSCSDTYI	OR5D18	181	Q8NGL1
DTYSECSEVDRSNSL	PCDH18	1021	Q9HCL0
ATSADRYTDVTTVLS	KIAA1549	316	Q9HCM3
ETVTVSVCLCSEGYS	ARHGEF28	66	Q8N1W1
TVCSSSEEQRAYSLS	ARHGEF28	576	Q8N1W1
KEYRSVLDDLTSCTT	ERCC6	131	P0DP91
VVSCSSLTSSLNYFD	PCDH19	801	Q8TAB3
TDTSTSYLLCISENK	MSH3	361	P20585
CPEATSESATELYTE	DGKK	66	Q5KSL6
VTITCRASQSISSYL	IGKV1D-39	41	P04432
RCTSSFSYLNLDTTE	HCFC2	281	Q9Y5Z7
TVESTSATCQVRTSY	KCNJ10	286	P78508
TNVADIYATSTCTEV	GPR176	181	Q14439
VTCTIKDVSSSVYST	KIT	231	P10721
LTFCTVSEASYELTQ	IGLV3-10	11	A0A075B6K4
CTYATALNVASLSVE	NTSR1	151	P30989
SGTYTCVANTTLDSV	NRCAM	611	Q92823
GSSSEEECTTSYLTL	RPS6KC1	501	Q96S38
TRLSASYEAVSACLS	MYO16	1306	Q9Y6X6
SVSVESACSNYATTV	LIMK2	166	P53671
QSKSTASFEELCSEY	SPINK5	426	Q9NQ38
ESDSATVYDNCASVS	MAPK8IP1	406	Q9UQF2
SIPRTASDTDSSYCI	GAB1	361	Q13480
RLVSSSCCIVTSTYS	HSP90AB2P	356	Q58FF8
IISSISEDLECYSST	KIF26B	1231	Q2KJY2
SSGRSESNLSSVCYI	APPL1	591	Q9UKG1
LDESECRVVKSTSYT	DCLK1	271	O15075
KTSYSASIEENCLSS	DSG4	271	Q86SJ6
AFYRLCSSSDTLVSE	FAM83B	796	Q5T0W9
VQSSYSTCVLVSEEN	FBP2	86	O00757
SFESIESYDSCDRLT	ETS1	251	P14921
ESVTRSSTETCYSAI	FLNB	2491	O75369
DAQEYEVSSSLVCIT	PLXNB1	1116	O43157
TVYNFCSEDTVREDT	PNLIPRP1	446	P54315
SLCDTFRDQSTYISA	NXF1	326	Q9UBU9
LCSTFSDQSAYVSAI	NXF5	221	Q9H1B4
PAVTILSCSDTSLYE	OR2T5	186	Q6IEZ7
QSGVIYCRDSDESSS	PDE8B	11	O95263
QSRDYVCLSSSDTLK	FAM221B	111	A6H8Z2
YTLSQTEVITDCSTR	GPR171	246	O14626
TVESTSAVCQSRTSY	KCNJ15	286	Q99712
CSEASSTYQRIAAIS	NFX1	901	Q12986
DSKFSTIASSYEECR	DPP3	496	Q9NY33
VESTTYSGCTTENLV	MED25	156	Q71SY5
VSTRTVSSEDKTECY	KCNRG	226	Q8N5I3
CTDGSSRAFSYTEVE	MUC5AC	5596	P98088
DETCTRFYTAEIVSA	PDPK2P	151	Q6A1A2
SSLDSLESCYLSEFQ	PCNT	966	O95613
SRSSVDVLYTFANCS	HPSE	166	Q9Y251
DSFLTVSSCQQVESY	BBS9	191	Q3SYG4
TCCVSESTLLYSIEE	LRRIQ1	726	Q96JM4
TSAQISDTGRYTCVA	HMCN1	2071	Q96RW7
PSVDDTATYECTVTN	HMCN1	3866	Q96RW7
LSETKTISYSECLTQ	OR1L1	136	Q8NH94
PAVTILSCSDTSLYE	OR2T29	186	Q8NH02
CARESASYSVTEVQL	BRIP1	401	Q9BX63
LVVTSANTENCSYES	PALLD	536	Q8WX93
YTSCDDVEIESESVS	RIMS2	556	Q9UQ26
VLQDSLDRCYSTTST	NBPF3	566	Q9H094
STLISSSQSCQYTLD	APOB	236	P04114
ADYVETVLDSTCSST	APOB	3906	P04114
NTLSVDCTRISFEYD	CDC45	261	O75419
TAITDSGTYECRVSE	CD101	501	Q93033
SSCSEFSKEAYTAVV	DOCK7	606	Q96N67
LASRSITEEVSEYCS	CSF1	26	P09603
STYVEFTVSGTDCVA	AHSG	196	P02765
TEDSGTYICEVTNTF	DSCAML1	286	Q8TD84
YLECILSVLSSSSSS	ARFGEF3	231	Q5TH69
YTCTAQTIVDNSSAS	CNTN1	581	Q12860
ATYTCVVSHEDSRTL	IGHD	351	P01880
VSDVSLSDEGQYTCS	CADM2	91	Q8N3J6
VTDVSEVCSIYTTAT	HASPIN	396	Q8TF76
SQKEESSATIYCSIR	LY9	616	Q9HBG7
VTITCRASQSISSYL	IGKV1-39	41	P01597
STIDLTCNDYISVFE	CBL	226	P22681
SESSLTCYELNTRKE	CCDC168	4436	Q8NDH2
YAENINTTSLTCSSD	CUZD1	266	Q86UP6
SSICDYTTFQIEVTK	DNAH2	2776	Q9P225
SVCVSSDYSIVNASV	SGK3	461	Q96BR1
YNVSCSSDEETQSLS	LIFR	571	P42702
TSLSSLEECQTTFSY	MDFIC2	76	A0A1B0GVS7
LEECQTTFSYLQTDT	MDFIC2	81	A0A1B0GVS7
TRSYDNLTTACDNTV	MTMR3	611	Q13615
VVDVLTSYESCNITS	INVS	236	Q9Y283
TSNSEDILSSACYTV	PKP1	651	Q13835
TSDKELYFSTTAVCI	SLC35A1	36	P78382
TGLYRDTQTSITDSC	SRPRB	86	Q9Y5M8
DTQTSITDSCAVYRV	SRPRB	91	Q9Y5M8
VYVSCIAQDTCTTTD	SPAG8	116	Q99932
VTTYNCAISSSDDRS	SMARCAD1	601	Q9H4L7
IESTRDSLCFTVTHY	PLEKHG3	351	A1L390
SSDGQLIATCSYDRT	PRPF4	501	O43172
YVTDSTISVSQCEIF	SAMD9L	931	Q8IVG5
TVATSYLSFCDSNVI	OR5AL1	176	P0C617
ICYITSTFASCSLED	HAO2	101	Q9NYQ3
YSDSVREVKSLSSCN	GCM2	401	O75603
SSTSSVYSTPEEKCQ	NAV2	1676	Q8IVL1
DLCSQYDLTVRSSTG	POLR3A	881	O14802
SDSVCYSVAVTRSRD	SIPA1L1	746	O43166
RSLYRTLSDESICSN	SIPA1L2	1481	Q9P2F8
SAEITCDLTVTNTFY	TRGV3	36	P03979
SVLCFTSSVDTRYQV	SLC26A10	241	Q8NG04
TDVCSVYSLDSVEEA	SH3TC1	406	Q8TE82
FVYRDVTDCTSVTGT	SSPN	176	Q14714
ASEAASYEFTTLTCI	DRG2	86	P55039
DFYTVETITSGSSCK	OLFML2B	101	Q68BL8
YAECVSDSSIFVQSR	SMAD9	346	O15198
QYSSCSTIFLDDSTA	AGAP5	141	A6NIR3
RCSVSTVSFDEESYE	C12orf42	111	Q96LP6
CNFSVSIYESVSETI	CLUL1	256	Q15846
TLESATSSQTSVYFC	TRBV10-3	96	A0A0K0K1G6
TCTTEDEIYSRICSE	ZNF615	66	Q8N8J6
VSYVECSSRSSERSV	RND2	156	P52198
TQTSTEYFLEACSRE	PLEK2	76	Q9NYT0
FSDIIYTVASCTENE	THOC2	1021	Q8NI27
SLTDSCINYSYLEDT	UNC80	621	Q8N2C7
CSITGDSSRVIAASY	WDR88	151	Q6ZMY6
SDIVTSRQSFYDCDS	ZNF568	166	Q3ZCX4
VISSSDDDSIVLYDC	WDR82	36	Q6UXN9
QSLTSVVSEECFYET	TIAM2	1681	Q8IVF5
ASVISTRCSETYETK	SUN2	556	Q9UH99
TRCSETYETKTALLS	SUN2	561	Q9UH99
VVSQRISTVDLSCYS	PHLPP2	246	Q6ZVD8
TELKTFANYSTCDRS	SARM1	471	Q6SZW1
ADNCVTDSLTIYDSL	TMPRSS7	296	Q7RTY8
AETVTLSCTYDTSES	TRA	36	P0DTU3
ATDDYFQCNTSSETV	STOX2	596	Q9P2F5
IRSRTSSDCTDAAYI	TRPM3	1306	Q9HCF6
SSDCTDAAYIVRQSS	TRPM3	1311	Q9HCF6
TAEYTSITDCIDTRC	TRPM3	1566	Q9HCF6
TDASSLVCYITRFTE	SLC4A10	611	Q6U841
TIREELCTASYDTIT	MID1	386	O15344
TLSEEAFLTINCTYT	TRAV9-2	31	A0A087WT02
SERDCESIYTISGTN	TMEM171	271	Q8WVE6
SYVSLSCDDFSSQEL	SLF1	651	Q9BQI6
TLESAASSQTSVYFC	TRBV10-1	96	A0A0K0K1A3
LSNDNLTVTCSSYDD	TRIM9	551	Q9C026
YENDTLLCTLSDSES	ZNF277	401	Q9NRM2
TDYTAVGCAITTISS	TLN2	571	Q9Y4G6
AETVTLSCTYDTSES	TRAV38-2DV8	36	A0JD32
TLESATRSQTSVYFC	TRBV10-2	96	A0A0K0K1G8
ICQEYRSTSATAVTF	TTC16	631	Q8NEE8
LRYITDCVDSLSLST	ZMYND10	191	O75800
LSTRCSETYETKTAL	SUN1	626	O94901
SATTDNEISRTEYLC	VEZT	651	Q9HBM0
YNCTLCSRSDTIDTV	POLR1B	1096	Q9H9Y6
ASTYPDTVTITSCVS	PTPRH	661	Q9HD43
LAEITESASLYFTCT	TG	1906	P01266
CSVLYLTSVETESLT	TNS2	1276	Q63HR2
YEECSSVFISCSSLS	ZNF195	356	O14628
DSAVIKCTYSDSASN	TRAV13-1	36	A0A0B4J241
YQTLLEATTSSDQCA	ZW10	491	O43264
TVDYSETSSLADPCS	ZFHX3	2911	Q15911
AETVTLSCTYDTSEN	TRAV38-1	36	A0A0B4J264
GRDCQSTATTVTYSE	VLDLR	746	P98155
SIDVSSYTEEFNVSC	HECTD3	246	Q5T447
SYTEEFNVSCLTDSN	HECTD3	251	Q5T447
ENSCISISQTSVYSE	KLRB1	186	Q12918
VESTSATCQVRTSYV	KCNJ1	301	P48048
LCYSEEDTFVDSSVT	MUC12	5281	Q9UKN1
TTDSDAKEIYERCTS	MYO5C	1646	Q9NQX4